Abzena has entered into a master service agreement with one of America’s leading academic medical centers, NYU Langone Health. The agreement, for protein engineering and drug discovery services, will help NYU Langone’s drug discovery accelerator, the Office of Therapeutics Alliances (OTA), to develop novel biopharmaceutical therapeutics. The first project under this master agreement centers around the development of a novel biopharmaceutical being developed by NYU OTA for the trea...